Renal cell carcinoma and brain metastasis: Questioning the dogma of role for cytoreductive nephrectomy

The increased utilization of cross-sectional imaging is at least partially responsible for the growing incidence of renal cell carcinoma (RCC) throughout the last 30 years. It has been estimated for 2018 that approximately 65,340 new patients will be diagnosed with RCC, over 60% incidentally, and about 14,970 patients will die from RCC [1]. Even with the increased detection of incidental renal masses, approximately 30% of patients still present with metastatic disease [2].

Source: Urologic Oncology: Seminars and Original Investigations - December 5, 2018 Category: Urology & Nephrology Authors: Michael Daugherty, Emily Daugherty, Joseph Jacob, Oleg Shapiro, Mehdi Mollapour, Gennady Bratslavsky Source Type: research